Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Showing results for noga day ag
Your search for Noga Dayag retrieved no results
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
Dimopoulos MA, Richardson PG, Bahlis NJ, Grosicki S, Cavo M, Beksaç M, Legieć W, Liberati AM, Goldschmidt H, Belch A, Magen H, Larocca A, Laubach JP, Petrucci MT, Reece D, White D, Mateos MV, Špička I, Lazaroiu M, Berdeja J, Kaufman JL, Jou YM, Ganetsky A, Popa McKiver M, Lonial S, Weisel K; ELOQUENT-1 investigators. Dimopoulos MA, et al. Lancet Haematol. 2022 Jun;9(6):e403-e414. doi: 10.1016/S2352-3026(22)00103-X. Epub 2022 May 9. Lancet Haematol. 2022. PMID: 35550060 Clinical Trial.
Patients in the elotuzumab plus lenalidomide and dexamethasone group received elotuzumab administered intravenously at 10 mg/kg on days 1, 8, 15, and 22 during cycles 1 and 2, days 1 and 15 during cycles 3-18, and then at 20 mg/kg on day 1 for subsequent cycles. In both tr …
Patients in the elotuzumab plus lenalidomide and dexamethasone group received elotuzumab administered intravenously at 10 mg/kg on days 1, 8 …
The Control of Novel and Traditional Elemental Impurities: Ag, Au, Co, Cs, Li, Mo, Se, Sr, and V in Mint Tea Infusions (Peppermint, Mentha piperita L.) Available in Poland: A Health Risk Assessment.
Milan J, Frydrych A, Noga M, Kondratowicz-Pietruszka E, Krośniak M, Jurowski K. Milan J, et al. Int J Environ Res Public Health. 2022 Dec 9;19(24):16564. doi: 10.3390/ijerph192416564. Int J Environ Res Public Health. 2022. PMID: 36554444 Free PMC article.
Silver and gold were present only in a few samples, and the estimated daily exposure for Ag is approximately 0.04575 g/day for product A and approximately 0.1885 g/day for product O, except for Au, which is in a range of 0.000356-0.114 g/L. The estimated dail …
Silver and gold were present only in a few samples, and the estimated daily exposure for Ag is approximately 0.04575 g/day for …
The Toxicological Analysis and Toxicological Risk Assessment of Chosen Elemental Impurities (Ag, Au, Co, Cr, Cs, Li, Mo, Se, and Sr) in Green Tea (Camellia sinensis (L.)) Infusions.
Frydrych A, Noga M, Milan J, Kondratowicz-Pietruszka E, Krośniak M, Jurowski K. Frydrych A, et al. Nutrients. 2023 Mar 17;15(6):1460. doi: 10.3390/nu15061460. Nutrients. 2023. PMID: 36986187 Free PMC article.
The PDE of lithium is around 560 mug/day, and according to our study, the estimated daily exposure of the evaluated products to Li fell between 0.0185 and 0.7170 mug/day. Our research also revealed modest concentrations of Cs (0.399-2.654 mug/L), Mo (0.0113-0.107 mu …
The PDE of lithium is around 560 mug/day, and according to our study, the estimated daily exposure of the evaluated products to Li fe …